Tavneos (avacopan) effectively induces disease remission in adults with ANCA-associated vasculitis (AAV) and diffuse alveolar hemorrhage (DAH), that…
Articles by Margarida Maia, PhD
Nearly one year of treatment with rituximab was superior to traditional immunosuppressive medications at helping people with ANCA-associated…
The combination antibiotic trimethoprim-sulfamethoxazole (TMP-SMX) may help prevent serious infections for people with granulomatosis with polyangiitis (GPA) who are taking…
Conduit Pharmaceuticals is planning to launch Phase 2a clinical trials to test its lead oral candidate AZD1656 in people…
The U.S. Food and Drug Administration (FDA) has given Nkarta the green light to launch a clinical trial testing…
Tavneos (avacopan) is better than the glucocorticoid prednisone at promoting disease remission, lowering relapse rates, and improving quality of…
Inflammatory bowel disease (IBD) — a chronic disease where the bowel becomes inflamed, causing recurring lower abdominal pain and diarrhea…
About 1 in every 5 people with ANCA-associated vasculitis (AAV), at some point in life, may experience problems that…
High blood levels of the protein CX3CL1, a pro-inflammatory immune signal that appears to be associated with blood vessel inflammation,…
Argenx has decided not to go ahead with its development plans for efgartigimod as a potential treatment for…